South Africa’s Aspen COVID-19 vaccine plant risks closure after no orders, executive says
TIM COCKS AFRICA'S first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated continent frustrated by sluggish Western handouts, risks shutting down after receiving not a single order, a company executive said. South Africa's Aspen Pharmacare negotiated a licensing deal in November to package and sell Johnson & Johnson's COVID-19 vaccine and distribute it across Africa. The World Health Organization (WHO) called the deal a "transformative moment" in the drive towards levelling stark inequalities in access to COVID vaccines. With only a sixth of adults in Africa fully vaccinated, according to the latest WHO figures from the end of…